Cargando…

Toward targeting B cell cancers with CD4(+) CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis

Some minor histocompatibility antigens (mHags) are expressed exclusively on patient hematopoietic and malignant cells, and this unique set of antigens enables specific targeting of hematological malignancies after human histocompatability leucocyte antigen (HLA)–matched allogeneic stem cell transpla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spaapen, Robbert M., Lokhorst, Henk M., van den Oudenalder, Kelly, Otterud, Brith E., Dolstra, Harry, Leppert, Mark F., Minnema, Monique C., Bloem, Andries C., Mutis, Tuna
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585855/ https://www.ncbi.nlm.nih.gov/pubmed/19001137 http://dx.doi.org/10.1084/jem.20080713

Ejemplares similares

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
por: Mutis, Tuna, et al.
Publicado: (2020)

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
por: Oostvogels, R, et al.
Publicado: (2013)

Concurrent Detection of Circulating Minor Histocompatibility Antigen-Specific CD8(+) T Cells in SCT Recipients by Combinatorial Encoding MHC Multimers
por: Broen, Kelly, et al.
Publicado: (2011)

siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice
por: van der Waart, Anniek B., et al.
Publicado: (2015)

Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design
por: Drent, Esther, et al.
Publicado: (2018)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells
por: Harimoto, Hirotomo, et al.
Publicado: (2013)

Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells
por: Harimoto, Hirotomo, et al.
Publicado: (2013)

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
por: Drent, Esther, et al.
Publicado: (2015)

IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8(+) T cells
por: Li, Lei, et al.
Publicado: (2017)

Correlation of peripheral CD4+GranzB+CTLs with disease severity in patients with primary Sjögren’s syndrome
por: Wang, Qi, et al.
Publicado: (2021)

Celiac CTLs change their stripes
por: Van Epps, Heather L.
Publicado: (2006)

CTLs: Killers of intracellular bacteria
por: Tian, Li, et al.
Publicado: (2022)

Minor H Antigen HA-1–specific Regulator and Effector CD8(+) T Cells, and HA-1 Microchimerism, in Allograft Tolerance
por: Cai, Junchao, et al.
Publicado: (2004)

Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019)

A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia
por: Dolstra, Harry, et al.
Publicado: (1999)

Hydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protection
por: Obeng-Adjei, N, et al.
Publicado: (2013)

Identifying a Minor Histocompatibility Antigen in Mauritian Cynomolgus Macaques Encoded by APOBEC3C
por: Weinfurter, Jason T., et al.
Publicado: (2020)

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers
por: Hasegawa, Atsuhiko, et al.
Publicado: (2011)

Minor Histocompatibility Antigen-Specific T Cells
por: Summers, Corinne, et al.
Publicado: (2020)

Iron Released after Cryo-Thermal Therapy Induced M1 Macrophage Polarization, Promoting the Differentiation of CD4(+) T Cells into CTLs
por: Wang, Shicheng, et al.
Publicado: (2021)

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer
por: Neklason, Deborah W, et al.
Publicado: (2010)

Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition
por: Cuenca, Marta, et al.
Publicado: (2021)

Cd1, Tuberculosis, and the Evolution of Major Histocompatibility Complex Molecules
por: Shinkai, Kanade, et al.
Publicado: (2000)

Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations
por: Spierings, Eric, et al.
Publicado: (2007)

CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice
Publicado: (1995)

Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA- B35 subtype molecules
Publicado: (1995)

CD4(+) CTLs Act as a Key Effector Population for Allograft Rejection of MSCs in a Donor MHC-II Dependent Manner in Injured Liver
por: Shen, Shuang, et al.
Publicado: (2022)

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
por: van der Veer, M S, et al.
Publicado: (2011)

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens
Publicado: (1975)

Reprogramming of CTLs into natural killer–like cells in celiac disease
por: Meresse, Bertrand, et al.
Publicado: (2006)

Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
por: Liu, Zhiyi, et al.
Publicado: (2014)

Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
por: Wefers, Christina, et al.
Publicado: (2018)

Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors
por: Ikeda, Hideki, et al.
Publicado: (2023)

A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR
por: Broen, Kelly, et al.
Publicado: (2011)

Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen encoded by an alternative ITGB2 transcript
por: Pont, Margot J, et al.
Publicado: (2015)

Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes
Publicado: (1988)

Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses
por: de Haart, S J, et al.
Publicado: (2016)

Lymphocyte-polarized DC1s: Effective inducers of tumor-specific CTLs
por: Berk, Erik, et al.
Publicado: (2012)

Signal strength controls the rate of polarization within CTLs during killing
por: Frazer, Gordon L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05c93kkqsemt3di4js8kshahqg